0001731038-18-000001.txt : 20180316 0001731038-18-000001.hdr.sgml : 20180316 20180316110519 ACCESSION NUMBER: 0001731038-18-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180316 DATE AS OF CHANGE: 20180316 EFFECTIVENESS DATE: 20180316 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Lindy Biosciences, LLC CENTRAL INDEX KEY: 0001731038 IRS NUMBER: 815178025 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-307909 FILM NUMBER: 18694648 BUSINESS ADDRESS: STREET 1: 100 CAPITOLA DRIVE STREET 2: SUITE 275 CITY: DURHAM STATE: NC ZIP: 27713 BUSINESS PHONE: 919-748-4480 MAIL ADDRESS: STREET 1: 100 CAPITOLA DRIVE STREET 2: SUITE 275 CITY: DURHAM STATE: NC ZIP: 27713 D 1 primary_doc.xml X0708 D LIVE 0001731038 Lindy Biosciences, LLC 100 CAPITOLA DRIVE SUITE 275 DURHAM NC NORTH CAROLINA 27713 919-748-4480 DELAWARE None None Limited Liability Company true 2016 Deborah Bitterfield 100 Capitola Dr Suite 275 Durham NC NORTH CAROLINA 27713 Executive Officer Director Promoter Manager Karen LeVert 100 Capitola Drive Suite 275 Durham NC NORTH CAROLINA 27713 Director Manager Biotechnology Decline to Disclose 06b false 2018-03-06 false true true true false 0 150000 150000 0 false 1 0 0 0 Proceeds will be used for working capital, which may include normal compensation to executive officers/managers. false Lindy Biosciences, LLC Deborah Bitterfield Deborah Bitterfield CEO 2018-03-15